VCLS and ERBC strengthen collaboration across non-clinical and regulated product development.
Collaboration announcementParis and Baugy, France · October 19, 2026
VCLS (Voisin Consulting Life Sciences) and ERBC are strengthening their collaboration to support pharmaceutical and biotechnology companies as they advance complex products through development.
Pictured above: members of the ERBC and VCLS teams at ERBC’s headquarters in Baugy, France.
The relationship brings together ERBC’s non-clinical scientific capabilities with VCLS’s expertise in regulatory strategy and life sciences product development. By connecting these complementary areas, the companies aim to help innovators make informed development decisions, anticipate regulatory requirements and establish clearer pathways towards clinical development and patient access.
“We are particularly pleased to strengthen our collaboration with VCLS. This reflects our ambition to build an increasingly comprehensive offering around our non-clinical expertise, enabling us to better support our clients throughout their development journey.”
CEO of ERBC Group
“Successful product development depends on making the right scientific and regulatory decisions at the right time. By strengthening our relationship with ERBC, we can connect complementary expertise across non-clinical development and regulatory strategy, helping innovators consider the evidence requirements and decisions that will shape the next stages of their programs. This is a practical collaboration built around a shared commitment to advancing complex products towards patients.”
CEO of VCLS
Drawing on their respective expertise, experience and international networks, ERBC and VCLS will introduce their capabilities where they can add value, helping clients align non-clinical programs with wider development and regulatory strategies.
Together, ERBC and VCLS are supporting a more strategic approach to complex drug development.
About VCLS
VCLS (Voisin Consulting Life Sciences) is a specialist life sciences product development partner helping biotech, pharmaceutical, and MedTech innovators advance complex products through regulated development and toward patient access. With expertise across regulatory strategy, clinical research, vigilance, real-world evidence, market access, and medical, scientific, and commercial communications, VCLS supports clients from early development planning through global submissions, market access, and lifecycle management. Our teams bring scientific depth, regulatory experience, and practical development insight to some of the most demanding areas of innovation, including orphan and rare diseases, advanced therapies, biologics, combination products, and medical devices.
About ERBC
ERBC (European Research Biology Center) is an independent European non-clinical contract research organization headquartered in Baugy, France, and organized around six sites in Europe. ERBC supports pharmaceutical, biotech, chemical, medical device and other product developers with non-clinical scientific services and models, from early research through regulatory studies.
Media contact
Anthony Murray, Marketing & Communications Manager, VCLS
anthony.murray@voisinconsulting.com